Platform Autoinjector Technologies for Enabling Next-Generation Combination Products
Day 3 Packaging & Device Innovation Stage
08/10/2026 13:00 - 13:30pm
Contributors
Siva Prasad Reddy BV : Technical Business Development Manager - Owen Mumford
The focus of this presentation is how platform autoinjector technologies can help pharmaceutical companies de-risk combination product development. As development timelines become increasingly compressed and biologics continue to dominate the pipeline, organizations are looking for ways to avoid the cost and complexity of custom device programs. I'll discuss how leveraging a validated platform approach, combined with flexibility around pre-filled syringe selection, can reduce technical, regulatory, and supply chain risks while accelerating the route to clinical studies and commercialization. I'll also share how the Aidaptus platform has been designed specifically to support these objectives and provide greater certainty throughout the development lifecycle.